Detalles de la búsqueda
1.
The impact of body mass index on the clinical features of bipolar disorder: A STEP-BD study.
Bipolar Disord
; 26(2): 160-175, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37536999
2.
Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial.
Eur Arch Psychiatry Clin Neurosci
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558147
3.
ABCB1 variants and sex affect serotonin transporter occupancy in the brain.
Mol Psychiatry
; 27(11): 4502-4509, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36071112
4.
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited.
Eur Arch Psychiatry Clin Neurosci
; 273(1): 51-63, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35262795
5.
Efficacy of Silexan in patients with anxiety disorders: a meta-analysis of randomized, placebo-controlled trials.
Eur Arch Psychiatry Clin Neurosci
; 273(7): 1615-1628, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36717399
6.
Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data.
Eur Arch Psychiatry Clin Neurosci
; 273(1): 65-74, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35217913
7.
Cariprazine for treating psychosis: an updated meta-analysis.
Int J Psychiatry Clin Pract
; 27(1): 107-109, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35544479
8.
Subthreshold depression - concept, operationalisation and epidemiological data. A scoping review.
Int J Psychiatry Clin Pract
; 27(1): 92-106, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736807
9.
Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.
Int J Psychiatry Clin Pract
; 27(3): 285-291, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021969
10.
Factors associated with sick leave duration in patients suffering from major depressive disorder initiating antidepressant treatment: a real-world evidence study in Germany and Spain.
Int J Psychiatry Clin Pract
; 27(1): 59-68, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35801359
11.
Regional gene expression patterns are associated with task-specific brain activation during reward and emotion processing measured with functional MRI.
Hum Brain Mapp
; 43(17): 5266-5280, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35796185
12.
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder.
Int J Neuropsychopharmacol
; 25(2): 118-127, 2022 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34637516
13.
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries.
Eur Arch Psychiatry Clin Neurosci
; 272(4): 715-727, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34989830
14.
Oxytocin receptor gene methylation as a molecular marker for severity of depressive symptoms in affective disorder patients.
BMC Psychiatry
; 22(1): 381, 2022 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35672748
15.
Subsyndromal generalised anxiety disorder: operationalisation and epidemiology - a systematic literature survey.
Int J Psychiatry Clin Pract
; 26(3): 277-286, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34314295
16.
Sick leave duration as a potential marker of functionality and disease severity in depression.
Int J Psychiatry Clin Pract
; 26(4): 406-416, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373692
17.
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideation.
Am J Med Genet B Neuropsychiatr Genet
; 189(3-4): 74-85, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35191176
18.
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.
N Engl J Med
; 389(10): 960, 2023 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672703
19.
No Abuse Potential of Silexan in Healthy Recreational Drug Users: A Randomized Controlled Trial.
Int J Neuropsychopharmacol
; 24(3): 171-180, 2021 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33300578
20.
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).
Int J Neuropsychopharmacol
; 24(1): 22-31, 2021 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861217